Journal of Cardiovascular Pharmacology and Therapeutics

SJR Rank #6,562H-index: 63SJR: 0.829Best quartile: Q2Open AccessAPC: US$1,325Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Cardiology and Cardiovascular MedicineQ2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cardiac electrophysiology and arrhythmiasCardiac Ischemia and ReperfusionAtrial Fibrillation Management and OutcomesLipoproteins and Cardiovascular HealthHeart Failure Treatment and ManagementAntiplatelet Therapy and Cardiovascular DiseasesCardiac Arrhythmias and TreatmentsCardiovascular Function and Risk FactorsAcute Myocardial Infarction ResearchCardiac Arrest and Resuscitation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs020406080

Documents per Year

2022202509182736

Detailed Information

ISSN

1074-2484, 1940-4034

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.09

References per Document

50.74

Coverage

1996-2025

Scope

Journal of Cardiovascular Pharmacology and Therapeutics is a peer-reviewed journal that publishes original clinical research focused on new and emerging therapies for cardiovascular diseases, and original preclinical research with clear translational relevance. The journal also publishes state-of-the-art review articles, commentaries and editorials, as well as selected supplements and focused issues.

Metrics from SCImago Journal Rank 2025. View on SCImago